Skip to content

Detection of Electrocardiographic Brugada Patterns Using High Precordial Leads

Detection of Electrocardiographic Brugada Patterns Using High Precordial Leads Positioning Among Asymptomatic Upper Egyptian Population

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05116488
Enrollment
300
Registered
2021-11-11
Start date
2021-12-31
Completion date
2023-12-31
Last updated
2021-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brugada ECG Patterns

Brief summary

Detection of prevalence of Brugada patterns in our locality in asymptomatic patients , by standard 12 lead ECG level and high precordial ECG level, measuring how much the high precordial leads is more sensitive in Brugada patterns detection than standard level 12 lead ECG in our upper Egyptian population.

Detailed description

Detection of prevalence of Brugada patterns in our locality in asymptomatic patients , by standard 12 lead ECG level and high precordial ECG level, measuring how much the high precordial leads is more sensitive in Brugada patterns detection than standard level 12 lead ECG in our upper Egyptian population. The study will include patients fulfilling our criteria presenting to cardiology outpatient clinic and emergency room of Assiut University hospitals.

Interventions

DIAGNOSTIC_TESTECG(electrocardigraph)

Detection of electrocardiographic Brugada patterns using high precordial leads positioning as placing the precordial leads in the second intercostal space has been proposed to add sensitivity to the ECG diagnosis of Brugada syndrome.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years

Inclusion criteria

1. patients with IHD,HTN,DM with no organic heart disease by ECHO. 2. healthy persons with normal structure heart by ECHO.

Exclusion criteria

1. Acute coronary syndrome. 2. cardiomyopathy. 3. severe valvular heart disease. 4. HTN heart disease with LVH. 5. Malignancy.

Design outcomes

Primary

MeasureTime frameDescription
Detection of electrocardiographic Brugada patterns using high precordial leads positioning among asymptomatic upper Egyptian populationup to 4 hours for each case to make sure of meeting eligibility criteriaDetection of prevalence of Brugada patterns in our locality in asymptomatic patients , by standard 12 lead ECG level and high precordial ECG level, measuring how much the high precordial leads is more sensitive in Brugada patterns detection than standard level 12 lead ECG in our upper Egyptian population.

Secondary

MeasureTime frameDescription
Follow up of positive casessix months after diagnosis of Brugada pattern for each caseThe positive cases will be educated regarding their condition, asked about their history of syncope and family history of sudden cardiac death and will be educated about avoiding and rapid management of fever and electrolyte disturbances and educated about the list of drugs to be avoided. The positive cases will be followed up for 6 months both clinically and by Holter at 1st, and 6th month for detection of subclinical ventricular arrhythmias.

Contacts

Primary ContactAlaa Rashad, Resident
alaarashad084@gmail.com01026453282
Backup ContactSalah Eldin Sayed Atta, Professor
salah_s_atta@hotmail.com01091318801

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026